Procedural Complexity and Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention
Authors:
- 5 January 2026
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 263, 43-52
Abstract
No abstract availableKeywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
This publication has 29 references indexed in Scilit:
- Five Years After ARC HBR’s Global Introduction: A Prospective Validation Study in EgyptThe American Journal of Cardiology, 2025
- Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registryAmerican Heart Journal, 2023
- Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCIJACC: Asia, 2023
- Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent ImplantationJAMA Cardiology, 2021
- Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI PatientsJACC, 2020
- Tailoring Dual Antiplatelet Therapy for the Complex PCI Patient: Current Status and PerspectivesCardiovascular Drugs and Therapy, 2020
- Ticagrelor With or Without Aspirin After Complex PCIJACC, 2020
- Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary StentingJACC, 2019
- Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary InterventionJACC, 2017
- Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCIJACC, 2016